Lucid Diagnostics Inc.
LUCD- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001799011
No open-market purchases or sales by Lucid Diagnostics Inc. insiders were filed in the last 90 days; 115 institutions reported holding it in 13F filings for Q2 2026, worth $65.7M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Lucid Diagnostics Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 19 | 18 | −1 |
| Shares | 1.77M | 1.86M | +95.3K (+5.4%) |
| Value | $2.49M | $2.59M | +$104.3K (+4.2%) |
New holders (2)
Institutions that held Lucid Diagnostics Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 62,511 | $86.9K | 0.00% |
| Royal Bank of Canada | 95 | $0 | 0.00% |
Sold out (3)
Institutions that held Lucid Diagnostics Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Virtu Financial LLC | 15,545 | $22.0K |
| UBS Group AG | 2,558 | $3.58K |
| Belpointe Asset Management LLC | 1,500 | $2.10K |